A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
Last year, Moderna completed a Phase I/II clinical trial of an investigational influenza vaccine called mRNA-1018, which was tested against H5 and H7 bird flu subtypes. The company said in a Jan. 17 ...
Q&A: From people avoiding wild birds to farmers protecting their animals, Kent State epidemiologist Dr. Tara Smith shares ...
Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.The biotech firm's mRNA-1018 candidate posted ...
ICMR seeks collaboration for H5N1 vaccine development to combat bird flu threat in India, emphasizing preparedness and public ...
According to the Centers for Disease Control and Prevention (CDC), there have been 67 confirmed human cases of H5N1 bird flu ...
Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...
The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, alongside other influenza vaccines, health officials ...